Firstly, we recommend Sinopharm Group investors take a look at the following interesting resources:
Cannabis Trader: http://cryptonewsjournal24.com/cannabis-trader-for-HK1099-investors
Trade Netflix: http://cryptonewsjournal24.com/netflix-for-HK1099-investors
Wall Street Journal: http://cryptonewsjournal24.com/wsj-for-HK1099-investors (only $12 for 12 weeks – everyone should get this)
REPORTING FOR 2019-07-22 | CRYPTONEWSJOURNAL24.COM: We have conducted a deep analysis of how Sinopharm Group (1099) has been trading over the last 2 weeks and the past day especially. On its latest session, Sinopharm Group (1099) opened at 30.05, reaching a high of 30.1 and a low of 29.7 before closing at a price of 29.85. There was a total volume of 749317.
VOLUME INDICATORS: We saw an accumulation-distribution index of 501.75, an on-balance volume of 30.0, chaikin money flow of 15.0 and a force index of 0.28. There was an ease of movement rating of -0.00208, a volume-price trend of -0.65138 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 0.64798, bolinger bands of 29.79571, an upper bollinger band of 29.65429, lower bollinger band of 29.7, a bollinger high band indicator of 1.0, bollinger low band indicator of nan, a central keltner channel of 29.95, high band keltner channel of 29.9, low band keltner channel of 30.0, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 29.7, a donchian channel low band of 29.7, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.00112, a MACD signal of 0.00062, a MACD difference of 0.0005, a fast Exponential Moving Average (EMA) indicator of 29.7, a slow Exponential Moving Average (EMA) indicator of 29.7, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 1.29874, a trix of 0.86965, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 0.697, a KST Oscillator (KST) of -22.92989 and a KST Oscillator (KST Signal) of -22.92989 (leaving a KST difference of 0.41122). We also found an Ichimoku rating of 30.075, an Ichimoku B rating of 30.075, a Ichimoku visual trend A of 30.72362, an Ichimoku visual trend B of 29.9165, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 50.20865, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -134.68013, a stochastic oscillator of 800.0, a stochastic oscillator signal of 800.0, a Williams %R rating of 700.0 and an awesome oscillator of -0.10167.
RETURNS: There was a daily return of -2.29299, a daily log return of 0.16821 and a cumulative return of 0.16835.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-22 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for Sinopharm Group (1099)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Sinopharm Group, we strongly advise Sinopharm Group investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like Sinopharm Group – without this you are trading blind:
We will of course continue to cover the news and price action of Sinopharm Group, but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Sinopharm Group (1099) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.